Journal Editors Press For More Disclosure Of Underlying Trial Data
This article was originally published in The Pink Sheet Daily
Executive Summary
The International Committee of Medical Journal Editors is collecting feedback on its plan to require clinical trial investigators to disclose patient-level data as a condition of publication.
You may also be interested in...
Cancer Moonshot Initiative: FDA To Form Virtual Oncology Center of Excellence
NIH and FDA would share $755m under FY 2017 budget proposal, part of $1bn the Obama Administration is targeting to jumpstart Moonshot.
Clinical Trial Transparency Gets A Boost With J&J Agreement, IOM Report
Johnson & Johnson's device and diagnostic clinical trial data is now available to independent researchers via Yale University’s Open Data Access (YODA) Project, announced the same day as an Institute of Medicine report mapping out strategies for clinical trial data-sharing.
Infuse Open-Access Project A Model For The Future? Medtronic Thinks So
Two independent analyses published last week on Medtronic’s Infuse biologic bone graft do not paint a positive picture for the device, but they do represent an important model for the future of open-access data analysis, both Medtronic and academic proponents say.